Talk:Main Page: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
=Welcome to the= | |||
{{DISPLAYTITLE:<span style="position: absolute; clip: rect(1px 1px 1px 1px); clip: rect(1px, 1px, 1px, 1px);">{{FULLPAGENAME}}</span>}} __NOTOC__ | {{DISPLAYTITLE:<span style="position: absolute; clip: rect(1px 1px 1px 1px); clip: rect(1px, 1px, 1px, 1px);">{{FULLPAGENAME}}</span>}} __NOTOC__ | ||
Revision as of 06:30, 24 September 2022
Welcome to the
About Us
The Umbrary is a private library network curated by Umbra.
- Provide resources for scientists and medical professionals in such areas such as hypermobility and transgender treatment.
- Reduce harm by bringing together official standards of care for gender identities and intersex conditions.
- Enable access to needed information freely to those who require help navigating the systems.
- Showcase accomplishments as a dynamic and growing curriculum vitae.
- Receive requests as a freelance research librarian.
Contact Us
The collection of libraries and lists on this website is curated by Umbra who can be contacted at umbrary@gmail.com.
You can request her services as a research librarian through the form found on the research requests page.
All Pages
Recent Changes
Research Updates
Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy.
A comparison between the ability of cyproterone acetate and spironolactone to lower testosterone levels. Although it shows that cyproterone has a greater effect towards lowering testosterone levels, it ironically notes this metric isn't very meaningful since spironolactone is only an antagonist and does not inhibit steroidogenesis.
The Papers page is a thorough compendium of up-to-date trans-specific research with a high quality of evidence, as well as guides on ways to access them or find more.
Featured Articles